Nutrition news

Rapid Nutrition expands distribution throughout South Korea

London, UK, January 6, 2022 (GLOBE NEWSWIRE) – Rapid Nutrition PLC (Euronext Growth: ALRPD, OTCQB: RPNRF), a natural healthcare company focused on sports nutrition, diet management and Life Science Products continues to expand distribution, with the expansion of its global distribution of its SystemLS biological health and wellness products throughout South Korea with the support of new partner SM Trading, a division of ‘Ilshin World Corporation. The announcement follows the company’s recent distribution deal with Zone Eight part of the RKSB group in Saudi Arabia last month.

Focusing on serving as the main distributor of imported products in South Korea, the warehouses owned by Ilshin Company enable top-notch logistics and distribution. Founded in 2000, Ilshin exclusively represents brands from around the world.

“We are extremely pleased with how our leadership team continues to execute our strategy of global expansion and meet key milestones,” said Simon St. Ledger, CEO of Rapid Nutrition. Likewise, we appreciate the expertise of Ilshin World Corporation across South Korea and are delighted to welcome this new partner and new global opportunity, as South Korea shows a strong interest in the healthcare category. organic.

South Korea’s health and wellness market continues to grow; The country reported 2018 sales of health and wellness products at nearly US $ 8 billion. The global COVID-19 pandemic has sparked more interest and sales of biologics in South Korea.

About fast nutrition

Dedicated to the development and distribution of premium scientific health and wellness brands around the world, Rapid Nutrition shares a host of award-winning products with consumers passionate about innovations “made by nature, refined by science. “. Rapid Nutrition’s first-class science team matches the experience of its leadership team to keep the company and consumers abreast of the latest industry trends and developments, while aligning with industry leaders. industry around the world to provide effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice in the world by delivering premium brands with the highest quality ingredients for optimal results.

For more information, please visit

Investor Relations Contact:
[email protected]


This press release contains forward-looking statements made in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and / or that involve risks, uncertainties and assumptions that could cause actual results and Rapid Nutrition PLC’s experience differed significantly from anticipated results. and the expectations expressed in these forward-looking statements. Rapid Nutrition PLC has, in some instances, identified forward-looking statements using words such as “anticipates”, “believes”, “hopes”, “believes”, “looks”, “expects”, “plans”, “Intends”, “” objective “,” potential “,” may “,” suggest “and similar expressions. Rapid Nutrition PLC does not undertake to release the results of any revision of these forward-looking statements which may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unforeseen events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell or a solicitation of an offer to buy securities. This information does not constitute an offer prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017 on the prospectus to be published when securities are offered to the public or admitted. trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the Euronext Exchange listing regulations or over-the-counter markets. The press release complies with the International Reporting Standard: Rule 12g3-2 (b) under the Securities Exchange Act (“rule 12g3-2 (b)”) allows non-US companies whose securities are primarily listed on a qualified foreign exchange to make publicly available to US investors in English, the same information that is made public in their home country as an alternative to rule 12g3-2 (b) of the SEC Reporting Exchange Act.